TrialAmerican journal of hematology2020

Phase 2 study of hyper-CMAD with liposomal vincristine for patients with newly diagnosed acute lymphoblastic leukemia.

Koji Sasaki et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.